Skip to content
Open access

Therapeutic targeting of cancer-associated fibroblasts with oncolytic virus in preclinical models of intrahepatic cholangiocarcinoma

Aug 2026 · Molecular therapy. Oncology · Vol 34, pp. 201325 · 0 citations · 45 references
Medicine

TL;DR

Using in vitro models with CAFs from patient-derived xenograft and syngeneic tumors, the effects of Vaccinia and vesicular stomatitis viruses found that OVs killed iCCA cells and CAFs, while also reducing pro-tumor CAF signaling.

Abstract

Intrahepatic cholangiocarcinoma (iCCA) is an aggressive malignancy with limited effective therapies. Treatment resistance is partly due to activated cancer-associated fibroblasts (CAFs), which induce pro-tumor signaling and formation of a highly fibrotic tumor microenvironment. CAFs exist on a functional spectrum of subtypes and are difficult to target in vivo. Oncolytic viruses (OVs) can destroy pro-tumor CAFs and reduce fibrosis. We hypothesized that OV infection both lyses CAFs and reprograms surviving CAFs toward a less tumorigenic phenotype. Using in vitro models with CAFs from patient-derived xenograft (PDX) and syngeneic tumors, we evaluated the effects of Vaccinia (VV) and vesicular stomatitis viruses (VSV) and found that OVs killed iCCA cells and CAFs, while also reducing pro-tumor CAF signaling. In vivo, subcutaneous PDX and syngeneic models evaluated OV efficacy, tumor architecture, and CAF function. OVs effectively killed iCCA cells and CAFs, alongside a significant reduction of pro-tumorigenic signaling from syngeneic CAFs. Tumor growth abrogation correlated with decreased inflammatory CAF signaling, namely, hepatocyte growth factor (HGF) production. Notably, HGF enhanced OV tropism, while OV infection reduced HGF expression, suggesting a CAF antiviral defense that also limits pro-tumor signaling. These findings suggest a dual cytotoxic and reprogramming role for OVs in the iCCA microenvironment.

Read PDF

Similar papers

Oct 2026

Systemic administration of poly(I:C) and resiquimod reprograms tumor-associated macrophages and prevents tumor progression and metastasis in murine cancer models.

It is demonstrated that intravenous administration of the poly(I:C)+R848 combination effectively reprograms TAMs, suppressing tumor progression and preventing metastasis across a variety of preclinical models of difficult-to-treat solid tumors.

Clément Anfray, A. Pensado-López, F. Castro et al. · 0 citations
Open access Sep 2026

Targeting pancreatic cancer with adenoviral vectors equipped with transgenes

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, and current therapeutics provide limited benefits to patients. Desmoplasia and the highly immunosuppressive tumor microenvironment (TME) play a huge role in PDAC being elusive to current therapeutics. Here, we strategically selected four transge...

Brett L. Roach, Mizuho Sato-Dahlman, Kari L. Jacobsen et al. · 0 citations
Review Open access Oct 2026

Cancer-associated fibroblasts as key mediators of therapeutic resistance and tumor progression in colorectal cancer

Cancer-associated fibroblasts (CAFs) are instrumental in tumor progression by interacting with tumor cells, other stromal components, and the extracellular matrix (ECM) within the tumor stroma. The origin, heterogeneity, and activation mechanisms of CAFs in different cancer types have been widely reported....

Bárbara Martins de Lima Coelho, L. B. Murad, R. Brandão-Costa et al. · 0 citations
Sep 2026

Abstract PR009: CD4+ T cells instruct cancer-associated fibroblasts to promote immune control of pancreatic cancer

Cancer-associated fibroblasts (CAFs) are key regulators of tumor progression and therapeutic response in pancreatic ductal adenocarcinoma (PDAC). While CAF-mediated immune modulation has been extensively studied, it remains poorly understood whether adaptive immune cells reciprocally shape CAF heterogeneity and funct...

Jessica Hung, Stephanie L. Silveria, Jenna Vickery et al. · 0 citations
Open access Nov 2026

MFAP2⁺ CAF reprogramming promotes bladder cancer invasion and an immunosuppressive microenvironment

Chemotherapy can reshape the bladder cancer stroma, but how tumor cells establish cancer-associated fibroblasts (CAF) states that support metastasis and immune suppression remains unclear. We investigated MFAP2-positive CAF using TCGA-BLCA and GEO cohorts, patient specimens, cell and mouse models, and single-cell and...

Guo-Li Sheng, Fan Wu, Ze-Hua Liu et al. · 0 citations
Open access Oct 2026

MHC-I downregulation is associated with immune-evasion in breast cancers with heterogeneous activation of epithelial-mesenchymal plasticity

Cancer cell-intrinsic epithelial-mesenchymal plasticity (EMP) drives carcinoma progression through increased intratumoral heterogeneity and an immunosuppressive tumor microenvironment (TME). Specifically, EMP activation in murine mammary carcinomas results in exclusion of CD8+ T-cells and recruitment of immunosuppressi...

Kimaya M. Bakhle, Andreas Stephanou, Sarthak Sahoo et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.